AssetMark Inc’s Vanda Pharmaceuticals VNDA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-31
| Closed | -$175 | – | 2367 |
|
|
2024
Q2 | $175 | Hold |
31
| – | – | ﹤0.01% | 2011 |
|
|
2024
Q1 | $127 | Hold |
31
| – | – | ﹤0.01% | 1811 |
|
|
2023
Q4 | $131 | Sell |
31
-26
| -46% | -$110 | ﹤0.01% | 1807 |
|
|
2023
Q3 | $246 | Hold |
57
| – | – | ﹤0.01% | 1617 |
|
|
2023
Q2 | $376 | Hold |
57
| – | – | ﹤0.01% | 1513 |
|
|
2023
Q1 | $387 | Hold |
57
| – | – | ﹤0.01% | 1506 |
|
|
2022
Q4 | $421 | Sell |
57
-28
| -33% | -$207 | ﹤0.01% | 1527 |
|
|
2022
Q3 | $1K | Sell |
85
-73,682
| -100% | -$867K | ﹤0.01% | 1491 |
|
|
2022
Q2 | $804K | Buy |
73,767
+15,400
| +26% | +$168K | ﹤0.01% | 551 |
|
|
2022
Q1 | $660K | Buy |
58,367
+14,357
| +33% | +$162K | ﹤0.01% | 570 |
|
|
2021
Q4 | $691K | Sell |
44,010
-2,756
| -6% | -$43.3K | ﹤0.01% | 486 |
|
|
2021
Q3 | $802K | Buy |
46,766
+3,949
| +9% | +$67.7K | ﹤0.01% | 408 |
|
|
2021
Q2 | $921K | Buy |
42,817
+5,392
| +14% | +$116K | ﹤0.01% | 394 |
|
|
2021
Q1 | $562K | Buy |
37,425
+8,722
| +30% | +$131K | ﹤0.01% | 431 |
|
|
2020
Q4 | $377K | Buy |
28,703
+4,644
| +19% | +$61K | ﹤0.01% | 471 |
|
|
2020
Q3 | $232K | Buy |
24,059
+11,752
| +95% | +$113K | ﹤0.01% | 501 |
|
|
2020
Q2 | $141K | Buy |
+12,307
| New | +$141K | ﹤0.01% | 535 |
|